SCHEMBL20427014

SCHEMBL20427014

c1ccc(-c2cc(-c3ccccc3)nc(-n3ccc4ccc5c(c43)-c3ccccc3C5(c3ccccc3)c3ccccc3)c2)cc1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20427025 0.87 COMT (0.34) —
SCHEMBL20427021 0.87 COMT (0.33) —
SCHEMBL20426915 0.86 MEN1 (0.32) PDK2
SCHEMBL20427003 0.86 MAPT (0.33) —
SCHEMBL20427033 0.86 CYP1A2 (0.31) —
SCHEMBL20426994 0.85 CHRNA7 (0.32) —
SCHEMBL20426964 0.84 — —
SCHEMBL20426999 0.83 CHRNA7 (0.31) —
SCHEMBL20427022 0.83 MAPT (0.34) —
SCHEMBL20427017 0.82 KMT2A (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same IDO1, IDO2, KYNU PDK2 1957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback